D.E. Shaw & Co
ASPX

D.E. Shaw & Co’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

D.E. Shaw & Co’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-21,737
Closed -$1.14M – 4306
2014
Q4 		$1.14M Buy
+21,737
New +$638K ﹤0.01% 2731
2014
Q3 		– Sell
-10,435
Closed -$232K – 4649
2014
Q2 		$232K Buy
+10,435
New +$228K ﹤0.01% 3928

Other funds holding ASPX

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

D.E. Shaw & Co's ASPX Position: Q1 2015 in Review

D.E. Shaw & Co sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q1 2015, closing a stake of 21,737 shares — an estimated $1.14M sold.

D.E. Shaw & Co first reported a position in ASPX in Q2 2014 and held it in 2 quarters. The position peaked at $1.14M in Q4 2014. 138 funds tracked by Wall St. Rank hold ASPX as of Q1 2015.

  • D.E. Shaw & Co reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • D.E. Shaw & Co sold 21,737 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q1 2015, an estimated $1.14M.
  • D.E. Shaw & Co first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 2 quarters.
  • D.E. Shaw & Co's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.14M in Q4 2014.
  • 138 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q1 2015.

Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.